AIFarm Financial Statements From 2010 to 2025
| AIFM Stock | USD 0 0.00 0.00% |
Check AIFarm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AIFarm's main balance sheet or income statement drivers, such as , as well as many indicators such as . AIFarm financial statements analysis is a perfect complement when working with AIFarm Valuation or Volatility modules.
AIFarm |
AIFarm Company EBITDA Analysis
AIFarm's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AIFarm EBITDA | (487.13 K) |
Most of AIFarm's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AIFarm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AIFarm reported earnings before interest,tax, depreciation and amortization of (487,134). This is 100.08% lower than that of the Industrials sector and significantly lower than that of the Farm & Heavy Construction Machinery industry. The ebitda for all United States stocks is 100.01% higher than that of the company.
AIFarm Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AIFarm's current stock value. Our valuation model uses many indicators to compare AIFarm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AIFarm competition to find correlations between indicators driving AIFarm's intrinsic value. More Info.AIFarm is rated second in return on asset category among its peers. It also is rated second in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIFarm's earnings, one of the primary drivers of an investment's value.About AIFarm Financial Statements
AIFarm investors utilize fundamental indicators, such as revenue or net income, to predict how AIFarm Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
AIFarm, Ltd., a development stage company, develops a proprietary growing system that designs and builds custom biodomes worldwide. AIFarm, Ltd. was founded in 2012 and is based in Kowloon, Hong Kong. Aifarm is traded on OTC Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in AIFarm Pink Sheet
AIFarm financial ratios help investors to determine whether AIFarm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AIFarm with respect to the benefits of owning AIFarm security.